JP2012525346A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525346A5
JP2012525346A5 JP2012507703A JP2012507703A JP2012525346A5 JP 2012525346 A5 JP2012525346 A5 JP 2012525346A5 JP 2012507703 A JP2012507703 A JP 2012507703A JP 2012507703 A JP2012507703 A JP 2012507703A JP 2012525346 A5 JP2012525346 A5 JP 2012525346A5
Authority
JP
Japan
Prior art keywords
bordetella pertussis
live
vaccine according
attenuated bordetella
pertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012507703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525346A (ja
JP5678034B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/055507 external-priority patent/WO2010125014A1/en
Publication of JP2012525346A publication Critical patent/JP2012525346A/ja
Publication of JP2012525346A5 publication Critical patent/JP2012525346A5/ja
Application granted granted Critical
Publication of JP5678034B2 publication Critical patent/JP5678034B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012507703A 2009-04-28 2010-04-26 アレルゲン駆動性気道病態の予防または治療のためのワクチン Active JP5678034B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305371 2009-04-28
EP09305371.8 2009-04-28
PCT/EP2010/055507 WO2010125014A1 (en) 2009-04-28 2010-04-26 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Publications (3)

Publication Number Publication Date
JP2012525346A JP2012525346A (ja) 2012-10-22
JP2012525346A5 true JP2012525346A5 (enExample) 2013-05-02
JP5678034B2 JP5678034B2 (ja) 2015-02-25

Family

ID=41057387

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012507703A Active JP5678034B2 (ja) 2009-04-28 2010-04-26 アレルゲン駆動性気道病態の予防または治療のためのワクチン

Country Status (10)

Country Link
US (7) US20120177688A1 (enExample)
EP (3) EP2424564B1 (enExample)
JP (1) JP5678034B2 (enExample)
CN (1) CN102448490B (enExample)
AU (1) AU2010243708C1 (enExample)
CA (1) CA2759280C (enExample)
DK (1) DK2424564T3 (enExample)
ES (2) ES3024937T3 (enExample)
SG (1) SG175803A1 (enExample)
WO (1) WO2010125014A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007224734C1 (en) 2006-03-10 2016-07-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Live attenuated Bordetella strains as a single dose vaccine against whooping cough
US20120177688A1 (en) 2009-04-28 2012-07-12 Institut Pasteur De Lille Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
EP2944320A1 (en) 2009-06-15 2015-11-18 National University of Singapore Influenza vaccine, composition, and methods of use
WO2013066272A1 (en) 2011-11-02 2013-05-10 National University Of Singapore Effect of an attenuated bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
CN105722530B (zh) 2013-08-16 2020-06-02 罗切斯特大学 用于紧密连接屏障调节的设计肽
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
CN114767718A (zh) * 2016-03-29 2022-07-22 里尔巴斯德研究所 突变型博德特氏菌属菌株及其使用方法
JP6598724B2 (ja) 2016-04-07 2019-10-30 株式会社ジェイテクト ステアリング装置
SG11202003333WA (en) 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
US20220249364A1 (en) 2019-06-05 2022-08-11 University Of Rochester Designed Inhibitors of Tight Junction Formation
EP4208472A1 (en) * 2020-09-04 2023-07-12 Intravacc B.V. Ompa mutations enhance omv production in bordetella pertussis
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) * 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
EP1617805A4 (en) * 2003-04-11 2012-07-04 Medimmune Llc METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
AU2007224734C1 (en) * 2006-03-10 2016-07-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Live attenuated Bordetella strains as a single dose vaccine against whooping cough
WO2008118592A2 (en) 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
CN100537767C (zh) * 2007-04-29 2009-09-09 中国药品生物制品检定所 百日咳疫苗保护性抗原的重组表达及其应用
US20120177688A1 (en) 2009-04-28 2012-07-12 Institut Pasteur De Lille Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
WO2013066272A1 (en) 2011-11-02 2013-05-10 National University Of Singapore Effect of an attenuated bordetella strain against allergic disease
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
CN114767718A (zh) 2016-03-29 2022-07-22 里尔巴斯德研究所 突变型博德特氏菌属菌株及其使用方法
US10799573B2 (en) 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
WO2018213361A1 (en) 2017-05-15 2018-11-22 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
CA3070039A1 (en) 2017-07-18 2019-01-24 Serum Institute Of India Pvt Ltd. An immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof
SG11202003333WA (en) 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
US12036405B2 (en) 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring

Similar Documents

Publication Publication Date Title
JP2012525346A5 (enExample)
Kong et al. Successful treatment of avian influenza with convalescent plasma
PH12019500289A1 (en) Vaccines directed against a human enteroviruses
US20080066739A1 (en) Methods and systems of delivering medication via inhalation
GEAP202115256A (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
EP2749284A3 (en) Combination of glycopyrronium and carmoterol
JP2015536134A5 (enExample)
CN103002896A (zh) 左西替利嗪和孟鲁司特在治疗流感、普通感冒和炎症中的用途
JP2013510169A5 (enExample)
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
JP2012527218A5 (enExample)
CY1117758T1 (el) Κουμπι επιστομιου εισπνευστηρα ξηρας κονεως
JP2014511897A5 (enExample)
Laiño et al. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
JP2014520854A5 (enExample)
JP2011068643A5 (enExample)
JP2010523662A5 (enExample)
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
Moinho Pneumococcal 13 valent CRM197 vaccine conjugate/pneumococcal 7 valent CRM197 vaccine conjugate
Lusuardi Challenging mucosal immunity with bacterial extracts to prevent respiratory infections: an old therapy revisited
GANIYEVA et al. RESPIRATORY DISEASES IN CHILDREN
Claude et al. B32 VIRAL INFECTION OF THE AIRWAY: Development Of Infant Respiratory Distress Syndrome In Response To Influenza A/pr/8/34 Infection
Ipe et al. The effect of nasal continuous positive airway pressure upon restless legs syndrome in sleep disordered breathing patients